14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.27 $7.87 Tuesday, 23rd Apr 2024 ARDX stock ended at $6.39. This is 1.84% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 5.33% from a day low at $6.38 to a day high of $6.72.
90 days $6.27 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
Jan 04, 2024 $6.15 $6.23 $6.08 $6.08 3 982 063
Jan 03, 2024 $5.97 $6.25 $5.92 $6.15 4 684 593
Jan 02, 2024 $6.14 $6.24 $5.95 $6.05 5 265 867
Dec 29, 2023 $6.41 $6.41 $6.18 $6.20 6 671 925
Dec 28, 2023 $6.51 $6.66 $6.36 $6.42 4 751 294
Dec 27, 2023 $6.53 $6.61 $6.44 $6.52 4 268 693
Dec 26, 2023 $6.38 $6.53 $6.28 $6.47 4 038 773
Dec 22, 2023 $6.34 $6.44 $6.28 $6.35 4 471 960
Dec 21, 2023 $6.12 $6.32 $6.11 $6.29 6 056 964
Dec 20, 2023 $6.71 $6.75 $5.92 $5.94 11 065 463
Dec 19, 2023 $6.35 $6.66 $6.29 $6.64 7 789 232
Dec 18, 2023 $6.07 $6.40 $5.98 $6.28 9 023 716
Dec 15, 2023 $5.87 $5.96 $5.60 $5.91 12 575 682
Dec 14, 2023 $5.52 $5.86 $5.48 $5.80 7 498 696
Dec 13, 2023 $5.27 $5.49 $5.25 $5.48 6 864 628
Dec 12, 2023 $5.17 $5.26 $5.03 $5.25 4 335 785
Dec 11, 2023 $5.27 $5.27 $4.98 $5.18 4 665 383
Dec 08, 2023 $5.28 $5.34 $5.18 $5.23 4 482 911
Dec 07, 2023 $5.20 $5.45 $5.17 $5.30 9 147 444
Dec 06, 2023 $5.02 $5.18 $4.96 $5.14 5 150 092
Dec 05, 2023 $4.93 $5.10 $4.87 $5.02 5 125 360
Dec 04, 2023 $4.68 $5.00 $4.62 $4.96 4 045 893
Dec 01, 2023 $4.50 $4.78 $4.47 $4.76 4 881 289
Nov 30, 2023 $4.39 $4.57 $4.37 $4.51 5 305 464
Nov 29, 2023 $4.11 $4.40 $4.11 $4.37 4 982 806
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT